| Literature DB >> 34897710 |
Brett L Ecker1, Brian C Brajcich2,3,4, Ryan J Ellis1,3,4, Clifford Y Ko3,4,5,6, Michael I D'Angelica1.
Abstract
Randomized controlled trials (RCTs) represent the gold standard for evidence in clinical medicine because of their ability to account for the effects of unmeasured confounders and selection bias by indication. However, their complexity and immense costs limit their application, and thus the availability of high-quality data to guide clinical care. Registry-based RCTs are a type of pragmatic trial that leverages existing registries as a platform for data collection, providing a low-cost alternative for randomized studies. Herein, we describe the tenets of registry RCTs and the development of the first AHPBA/ACS-NSQIP-based registry trial.Entities:
Keywords: pragmatic clinical trial; randomized controlled trials; registry-based trials; surgical registry; surgical research methods
Mesh:
Year: 2022 PMID: 34897710 PMCID: PMC8787438 DOI: 10.1002/jso.26742
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 3.454